Does AXITINIB Cause Off label use? 1,075 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,075 reports of Off label use have been filed in association with AXITINIB (INLYTA). This represents 6.8% of all adverse event reports for AXITINIB.
1,075
Reports of Off label use with AXITINIB
6.8%
of all AXITINIB reports
338
Deaths
178
Hospitalizations
How Dangerous Is Off label use From AXITINIB?
Of the 1,075 reports, 338 (31.4%) resulted in death, 178 (16.6%) required hospitalization, and 12 (1.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 1,075 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
Blood pressure increased (756)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AXITINIB Alternatives Have Lower Off label use Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE